Press Release | Association for Accessible Medicines

President Trump Drug Pricing Speech

May 11, 2018 | Rachel Schwartz

Generic and Biosimilar Competition Is Cornerstone of President Trump’s Blueprint to Lower Drug Prices for American Patients

AAM Statement on Oil States Energy Services v. Greene's Energy Group

Apr 24, 2018 | Rachel Schwartz

AAM Statement on Oil States Energy Services v. Greene's Energy Group

Apr 18, 2018 | Rachel Schwartz

AAM Announces 2018 Associate Members

Apr 18, 2018 | Rachel Schwartz

AAM Announces New Board Member and Additional Members

Apr 13, 2018 | Rachel Schwartz

AAM Statement on U.S. Court of Appeals Ruling on Maryland HB 631

ASAE Announces 2018 Gold Circle Award Winners

Apr 11, 2018 | Rachel Schwartz

AAM Receives Two ASAE 2018 Gold Circle Awards

Apr 9, 2018 | Rachel Schwartz

AAM Launches Code of Business Ethics

AAM - Your Generics & Biosimilars Industry

Apr 4, 2018 | Rachel Schwartz

AAM Statement on China Tariffs

Mar 28, 2018 | Rachel Schwartz

AAM Statement on Generic and Biosimilar Drugmaker Inability to Acquire Samples

CREATES Act Statement - Capitol Building, DC

Mar 20, 2018 | Rachel Schwartz

AAM Statement — Restricting Patent Settlements Hurts Patients

STAT: Grassley, Leahy

Mar 16, 2018 | Rachel Schwartz

Op-Ed from STAT — Grassley, Leahy: It's Time to Empower Generic Drug Makers to Bring Down Prices

AAM Statement on PACED Act of 2018

Mar 8, 2018 | Rachel Schwartz

AAM Statement on PACED Act of 2018